Why the study?
Do point-of-care monitors (mTEG and PFA-100) accurately identify the antiplatelet effect of aspirin and clopidogrel compared to optical light transmission aggregometry?
Population
Patients taking aspirin (n=20) and/or clopidogrel
Comparison
Point-of-care platelet function monitoring using… vs Optical light transmission aggregometry
Design
Cross-sectional
Authors
Loading...
Supports mTEG for POC antiplatelet monitoring; leaves open prospective outcome validation before clinical adoption.
Do point-of-care monitors (mTEG and PFA-100) accurately identify the antiplatelet effect of aspirin and clopidogrel compared to optical light transmission aggregometry?
Modified thromboelastography (mTEG) is an effective point-of-care monitor for detecting the antiplatelet effects of both aspirin and clopidogrel, outperforming the PFA-100 for clopidogrel.
Agarwal et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: